Please use this identifier to cite or link to this item: http://hdl.handle.net/20.500.12188/8251
DC FieldValueLanguage
dc.contributor.authorNatasha Simonovskaen_US
dc.contributor.authorAndon Chibisheven_US
dc.contributor.authorAleksandra Babulovskaen_US
dc.contributor.authorZanina Pereskaen_US
dc.contributor.authorIrena Jurukoven_US
dc.contributor.authorMarija Glasnovicen_US
dc.date.accessioned2020-05-21T17:53:56Z-
dc.date.available2020-05-21T17:53:56Z-
dc.date.issued2011-
dc.identifier.issn1512-7680-
dc.identifier.urihttp://hdl.handle.net/20.500.12188/8251-
dc.description.abstractThe program of our Clinic includes, not only treatment of acute intoxication with opioids and other drugs, but also comprehends clinical investigations and treatment of the somatic complications of this population. For the first time in our country our Clinic offers to this population the alternative way of treatment with Buprenorfin. The Clinic started with this protocol on August 1, 2009. During a period of two years, the treatment with Buprenorfine has been initiated in 353 patients, of which 211 regularly attend the medical check ups. This model is used according to the national clinical guidelines and procedures for the use of buprenorfine in the treatment of opioid dependence The dose of this medicament depends on the evolution of the withdrawal symptoms. We have used the objective and subjective opioid withdrawal scale for the observation of these symptoms (OOWS ; SOWS - Handelsman et al 1987). This protocol starts with a complete clinical investigations, (i.e. where all patients undergo the inclusion and exclusion criteria with a written consent). Afterwards, the patients are hospitalized and start with a Buprenorfin teratment. After period of 7-10 days hospitalization they come to our Clinic, like outpatients for a regular controls. We have precise evidence for every patient who comes for control (e.g. medical record with all biochemical and toxicological screenings). All patients are recommended a tight cooperation with psychiatrists who are specialized to treat the problematic drug addictions.en_US
dc.language.isoenen_US
dc.publisherScopeMed Publishingen_US
dc.relation.ispartofMateria Socio-medicaen_US
dc.subjectBuprenorfinen_US
dc.subjectnational guidelinesen_US
dc.subjectopioid addictsen_US
dc.subjectwithdrawal scalesen_US
dc.titleProgram of the University Clinic of Toxicology, Skopje, Republic of Macedonia in treatment of drug addiction (buprenorfin treatment protocol)en_US
dc.typeArticleen_US
dc.identifier.doi10.5455/msm.2011.23.232-234-
dc.identifier.urlhttp://www.scopemed.org/fulltextpdf.php?mno=13929-
dc.identifier.volume23-
dc.identifier.issue4-
item.grantfulltextopen-
item.fulltextWith Fulltext-
crisitem.author.deptFaculty of Medicine-
crisitem.author.deptFaculty of Medicine-
crisitem.author.deptFaculty of Medicine-
Appears in Collections:Faculty of Medicine: Journal Articles
Files in This Item:
File Description SizeFormat 
MSM-program buprenorfine.pdf101.69 kBAdobe PDFThumbnail
View/Open
Show simple item record

Page view(s)

94
checked on May 1, 2024

Download(s)

14
checked on May 1, 2024

Google ScholarTM

Check

Altmetric


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.